Overview

Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This study is to determine the change in blood pressure from the administration of Olmesartan/Amlodipine/Hydrochlorothiazide triple combinations compared to dual combinations with Olmesartan/Amlodipine.
Phase:
Phase 3
Details
Lead Sponsor:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Treatments:
Amlodipine
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
Hydrochlorothiazide
Olmesartan
Olmesartan Medoxomil